Across
- 4. Semisynthetic opioid commonly combined with acetaminophen
- 8. metabolite that can accumulate and causes seizures
- 11. Brand name for fentanyl transdermal system
- 12. Brand name of naloxone nasal spray
- 14. Brand name of buprenorphine/naloxone combination
- 15. High-potency synthetic opioid; CYP3A4 substrate; significant overdose risk with inhibitors
- 16. brand name of opioid that has deadly drug interaction with MAO inhibitors
- 18. Partial μ-agonist used in opioid use disorder
- 21. OTC peripheral μ-agonist used for diarrhea
- 22. OTC antitussive with abuse potential at high doses
Down
- 1. non-opioid allosteric inhibitor of peripheral sodium NaV1.8 channels
- 2. Gold-standard opioid for severe pain; active metabolite of heroin
- 3. Prodrug requiring CYP2D6 for conversion to morphine; ineffective in poor metabolizers
- 5. causes precipitated withdrawal in patients on chronic opioids
- 6. short acting opioid antagonist used for overdose reversal
- 7. Weak μ-agonist + SNRI activity; seizure risk
- 9. for intrathecal administration only
- 10. Highly potent synthetic opioid; transdermal patch available
- 11. prescription antidiarrheal combined with atropine
- 13. Brand name of extended-release oxycodone
- 15. opioid with lowest histamine release
- 17. Long-acting opioid; QT prolongation risk
- 19. biased μ-agonist designed to reduce β-arrestin–mediated respiratory depression
- 20. Brand name for hydromorphone
